Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

100%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
4(100.0%)
4Total
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02390687Phase 3Completed

Evaluation of the Efficacy of Probiotics in Chronic Periodontitis Patients

Role: lead

NCT02329353Phase 3Completed

Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers

Role: lead

NCT02545413Phase 3Withdrawn

Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome

Role: lead

NCT02357771Phase 3Completed

Probiotic Lozenge Reduce Streptococcus Mutans in Plaque in Orthodontic Bracket Patients

Role: lead

All 4 trials loaded